MCM
AGN

Mengis Capital Management’s Allergan plc AGN Stock Holding History

Mengis Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,946
Closed -$521K – 159
2020
Q1 		$521K Hold
2,946
– – 0.18% 103
2019
Q4 		$563K Hold
2,946
– – 0.16% 109
2019
Q3 		$495K Hold
2,946
– – 0.15% 115
2019
Q2 		$493K Buy
+2,946
New +$408K 0.15% 115

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Mengis Capital Management's AGN Position: Q2 2020 in Review

Mengis Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,946 shares — an estimated $521K sold.

Mengis Capital Management first reported a position in AGN in Q2 2019 and held it in 4 quarters. The position peaked at $563K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Mengis Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Mengis Capital Management sold 2,946 Allergan plc shares in Q2 2020, an estimated $521K.
  • Mengis Capital Management first reported a position in Allergan plc in Q2 2019 and held it in 4 quarters.
  • Mengis Capital Management's Allergan plc position peaked at $563K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Mengis Capital Management's 13F filing for Q2 2020, filed 22 Jul 2020.